Doctor profile · Federal record

Dr. Joshua Sundhar, MD

Rheumatology Physician (CMS: Rheumatology) · Voorhees, NJ

  • NPI 1760623193
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 20 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2301 E. Evesham Road, Bldg 800, Suite 115
Voorhees, NJ 08043
(856) 424-5005
fax (856) 424-4716

Credentials & registration

NPPES · NUCC
NPI registered
March 2009 — 17 yrs on file
Profile last updated
May 16, 2018
Year of graduation
2006 — 20 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
New Jersey #25MA09060500

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1760623193. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
72,782
Distinct HCPCS
10
Medicare allowed
$972,482
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 28,160 20 $6
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 24,000 34 $5
J1602 Injection, golimumab, 1 mg, for intravenous use 6,100 22 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 5,000 24 $42
J0897 Injection, denosumab, 1 mg 4,560 46 $23
J1745 Injection, infliximab, excludes biosimilar, 10 mg 3,150 30 $33
99214 Established patient office or other outpatient visit, 30-39 minutes 500 281 $137
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 243 90 $81
96413 Administration of chemotherapy into vein, 1 hour or less 219 101 $147
J1030 Injection, methylprednisolone acetate, 40 mg 179 82 $8

In context: peer comparison

Among 10 peers in this city , average services per provider: 3,572. This provider delivers 20× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,528
Transactions
18
Manufacturers
5
Payer (manufacturer) Industry Txns Amount
Amgen Inc. 7 $891.84
ABBVIE INC. 4 $274.06
GlaxoSmithKline, LLC. 4 $247.79
Janssen Biotech, Inc. 2 $96.52
AstraZeneca Pharmaceuticals LP 1 $18.18

By nature of payment

Food and Beverage
$848
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$600
Education
$80

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,008
Patients
607
Total drug cost
$585,393
Drug Type Claims Patients Total cost
Tramadol Hcl Generic 399 94 $2,818
Hydroxychloroquine Sulfate Generic 336 107 $22,725
Methotrexate (Methotrexate Sodium) Brand 319 107 $14,100
Prednisone Generic 281 87 $3,543
Duloxetine Hcl Generic 117 39 $4,047
Methylprednisolone Generic 84 52 $785
Leflunomide Generic 80 23 $9,114
Gabapentin Generic 78 24 $2,086
Folic Acid Generic 76 23 $276
Allopurinol Generic 56 17 $1,964

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Joshua Sundhar's medical specialty?
Dr. Joshua Sundhar practices Rheumatology Physician in Voorhees, NJ.
Where does Dr. Joshua Sundhar practice?
Dr. Joshua Sundhar practices at 2301 E. Evesham Road, Voorhees, NJ 08043. Office phone: 8564245005.
What is Dr. Joshua Sundhar's NPI?
Dr. Joshua Sundhar's National Provider Identifier (NPI) is 1760623193, issued by NPPES.
Does Dr. Joshua Sundhar accept Medicare assignment?
Yes. Dr. Joshua Sundhar accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Joshua Sundhar commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.